1. Efficacy and Safety of Elective Switching from Intravenous to Subcutaneous Infliximab [CT-P13]: A Multicentre Cohort Study. (7th April 2022) Authors: Smith, Philip J; Critchley, Lisa; Storey, Daniel; Gregg, Belle; Stenson, June; Kneebone, Andrew; Rimmer, Tracy; Burke, Stevena; Hussain, Shamas; Yi Teoh, Wan; Vazeille, Stephan; Serna, Solange; Steel, Alan; Derbyshire, Edmund; Collins, Paul; Dibb, Martyn; Flanagan, Paul; Probert, Christopher; Ver... Journal: Journal of Crohn's and colitis Issue: Volume 16:Number 9(2022) Page Start: 1436 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗